Shares of Aura Biosciences, Inc. (AURA) have gained 1.8% over the past four weeks to close the last trading session at $7.52, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $19.75 indicates a potential upside of 162.6%.The average comprises four short-term price targets ranging from a low of $19 to a high of $21, with a standard deviation of $0.96. While the lowest estimate ind ...